{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:19:38Z","timestamp":1791425978432,"version":"4.3.3"},"reference-count":51,"publisher":"Elsevier BV","issue":"8","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.vaccine.2013.12.050","type":"journal-article","created":{"date-parts":[[2014,1,4]],"date-time":"2014-01-04T08:30:39Z","timestamp":1388824239000},"page":"949-956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Recombinant chimeric Japanese encephalitis virus\/tick-borne encephalitis virus is attenuated and protective in mice"],"prefix":"10.1016","volume":"32","author":[{"given":"Hong-Jiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Qiang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E-De","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Feng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 40","key":"10.1016\/j.vaccine.2013.12.050_bib0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijmm.2006.01.023","article-title":"Specific clinical and epidemiological features of tick-borne encephalitis in Western Siberia","volume":"296","author":"Poponnikova","year":"2006","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0166-3542(02)00206-1","article-title":"Tick-borne encephalitis","volume":"57","author":"Gritsun","year":"2003","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0015","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(08)60800-4","article-title":"Tick-borne encephalitis","volume":"371","author":"Lindquist","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0020","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.virusres.2005.04.007","article-title":"Steps of the tick-borne encephalitis virus replication cycle that affect neuropathogenesis","volume":"111","author":"Mandl","year":"2005","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0025","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.idc.2008.03.013","article-title":"Tick-borne encephalitis","volume":"22","author":"Kaiser","year":"2008","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ttbdis.2010.10.007","article-title":"Tick-borne encephalitis 2010: epidemiology, risk areas, and virus strains in Europe and Asia-an overview","volume":"2","author":"Suss","year":"2011","journal-title":"Ticks Tick Borne Dis"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0035","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1099\/vir.0.011437-0","article-title":"Tick-borne encephalitis virus\u2014a review of an emerging zoonosis","volume":"90","author":"Mansfield","year":"2009","journal-title":"J Gen Virol"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2013.12.050_bib0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1099\/0022-1317-80-1-179","article-title":"Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia","volume":"80","author":"Ecker","year":"1999","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0045","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1586\/14760584.4.5.747","article-title":"Tick-borne encephalitis vaccines: past and present","volume":"4","author":"Zent","year":"2005","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0050","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.vaccine.2009.02.069","article-title":"Characterization of neutralizing antibodies to Far Eastern of tick-borne encephalitis virus subtype and the antibody avidity for four tick-borne encephalitis vaccines in human","volume":"27","author":"Leonova","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0055","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1016\/j.vaccine.2007.08.024","article-title":"Field effectiveness of vaccination against tick-borne encephalitis","volume":"25","author":"Heinz","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0060","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0264-410X(02)00593-5","article-title":"Tolerability of modified tick-borne encephalitis vaccine FSME-IMMUN \u201cNEW\u201d in children: results of post-marketing surveillance","volume":"21","author":"Pavlova","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0065","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1016\/S0264-410X(03)00421-3","article-title":"Safety, immunogenicity and tolerability of a new pediatric tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer","volume":"21","author":"Zent","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0070","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00415-004-0329-z","article-title":"Two severe cases of tick-borne encephalitis despite complete active vaccination\u2014the significance of neutralizing antibodies","volume":"251","author":"Bender","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0075","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s15010-006-6614-2","article-title":"Delayed humoral immunity in a patient with severe tick-borne encephalitis after complete active vaccination","volume":"35","author":"Kleiter","year":"2007","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0080","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10354-005-0178-0","article-title":"The golden agers and tick-borne encephalitis. Conference report and position paper of the International Scientific Working Group on Tick-borne encephalitis","volume":"155","author":"Kunze","year":"2005","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0085","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.1016\/j.vaccine.2009.09.069","article-title":"Characteristics of antibody responses in tick-borne encephalitis vaccination breakthroughs","volume":"27","author":"Stiasny","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0090","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1016\/j.vaccine.2010.09.003","article-title":"Tick-borne encephalitis after vaccination: vaccine failure or misdiagnosis","volume":"28","author":"Grgic-Vitek","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0095","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1016\/j.vaccine.2010.02.001","article-title":"Vaccine failures after active immunisation against tick-borne encephalitis","volume":"28","author":"Andersson","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.vaccine.2007.11.009","article-title":"TBE infection in an incomplete immunized person at-risk who lives in a high-endemic area\u2014impact on current recommendations for immunization of high-risk groups","volume":"26","author":"Plisek","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0105","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1128\/JVI.76.7.3534-3543.2002","article-title":"Capsid protein C of tick-borne encephalitis virus tolerates large internal deletions and is a favorable target for attenuation of virulence","volume":"76","author":"Kofler","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0110","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1128\/JVI.07125-11","article-title":"MicroRNA targeting of neurotropic flavivirus: effective control of virus escape and reversion to neurovirulent phenotype","volume":"86","author":"Heiss","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0115","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1128\/JVI.02091-10","article-title":"Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype","volume":"85","author":"Heiss","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0120","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.vaccine.2007.12.015","article-title":"Evaluation of the Langat\/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers","volume":"26","author":"Wright","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.vaccine.2005.07.067","article-title":"Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys","volume":"24","author":"Rumyantsev","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0130","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1073\/pnas.95.4.1746","article-title":"Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4","volume":"95","author":"Pletnev","year":"1998","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0135","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1006\/viro.2000.0426","article-title":"Chimeric Langat\/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus","volume":"274","author":"Pletnev","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0140","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1016\/j.vaccine.2010.02.105","article-title":"Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities","volume":"28","author":"Yu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0145","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1016\/j.vaccine.2007.04.052","article-title":"Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization","volume":"25","author":"Tandan","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0150","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMc0808664","article-title":"Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis","volume":"360","author":"Kumar","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0155","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0140-6736(96)91075-2","article-title":"Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study","volume":"347","author":"Hennessy","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0160","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.vaccine.2008.02.042","article-title":"Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants","volume":"26","author":"Gatchalian","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0165","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0140-6736(01)05967-0","article-title":"Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study","volume":"358","author":"Bista","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0170","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.1128\/JVI.02806-12","article-title":"Rational design of a flavivirus vaccine by abolishing viral RNA 2\u2032-O methylation","volume":"87","author":"Li","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0175","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00705-011-1031-y","article-title":"Complete genome sequence analysis of tick-borne encephalitis viruses isolated in northeastern China","volume":"156","author":"Si","year":"2011","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0180","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1099\/vir.0.043844-0","article-title":"A single nucleotide mutation in NS2A of Japanese encephalitis-live vaccine virus (SA14-14-2) ablates NS1\u2032 formation and contributes to attenuation","volume":"93","author":"Ye","year":"2012","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0185","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0190","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1128\/JVI.73.10.8083-8094.1999","article-title":"Mutagenesis of the NS2B-NS3-mediated cleavage site in the flavivirus capsid protein demonstrates a requirement for coordinated processing","volume":"73","author":"Amberg","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0195","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1128\/JVI.69.4.1995-2003.1995","article-title":"Formation of the flavivirus envelope: role of the viral NS2B-NS3 protease","volume":"69","author":"Yamshchikov","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0200","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1128\/JVI.78.1.178-186.2004","article-title":"Inefficient signalase cleavage promotes efficient nucleocapsid incorporation into budding flavivirus membranes","volume":"78","author":"Lobigs","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0205","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1073\/pnas.022652799","article-title":"West Nile virus\/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy","volume":"99","author":"Pletnev","year":"2002","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0210","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/JVI.73.4.3095-3101.1999","article-title":"Yellow fever\/Japanese encephalitis chimeric viruses: construction and biological properties","volume":"73","author":"Chambers","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0215","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1128\/JVI.74.12.5477-5485.2000","article-title":"Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates","volume":"74","author":"Guirakhoo","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0220","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/vbz.2010.0179","article-title":"Chimeric tick-borne encephalitis\/dengue virus is attenuated in Ixodes scapularis ticks and Aedes aegypti mosquitoes","volume":"11","author":"Engel","year":"2011","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0225","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1016\/S0264-410X(03)00488-2","article-title":"Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys","volume":"21","author":"Whitehead","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0230","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.2001.65.405","article-title":"Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3\u2032-untranslated region","volume":"65","author":"Durbin","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0235","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1128\/JVI.74.7.3020-3028.2000","article-title":"Chimeric dengue type 2 (vaccine strain PDK-53)\/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine","volume":"74","author":"Huang","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0240","doi-asserted-by":"crossref","first-page":"10532","DOI":"10.1073\/pnas.89.21.10532","article-title":"Construction and characterization of chimeric tick-borne encephalitis\/dengue type 4 viruses","volume":"89","author":"Pletnev","year":"1992","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0245","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","article-title":"ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy","volume":"78","author":"Arroyo","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0250","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1128\/JVI.79.12.7300-7310.2005","article-title":"Chimeric dengue 2 PDK-53\/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus","volume":"79","author":"Huang","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.12.050_bib0255","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/649916","article-title":"A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults","volume":"201","author":"Morrison","year":"2010","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13017933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13017933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T10:55:54Z","timestamp":1597316154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13017933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0264410X13017933"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant chimeric Japanese encephalitis virus\/tick-borne encephalitis virus is attenuated and protective in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}